The latest news on MS treatments, research and specialist services.
MS Trust news
News from the MS Trust
Views and comment
MS Trust staff, MS health professionals and people with MS offer their perspectives on hot topics in the world of MS
Our free, quarterly newsletter for people with multiple sclerosis, their family and friends and supporters of the MS Trust.
Read our latest news
- ESA re-assessments
- NICE turns down daclizumab
- Mindfulness helps with coping
- Tysabri vs Gilenya comparison
The government are to scrap repeat assessments of people claiming ESA (Employment Support Allowance) if they have a condition that is unlikely to have improved.
Sleepless nights and jars of chutney from a neighbour inspired Marie to create her own cook book, which she is now using to raise funds to help others with MS.
Reports of studies presented at the ECTRIMS meeting that took place from 14-17 September 2016. Reports include research into disease modifying drugs for relapsing and progressive MS, stem cells and lifestyle factors in MS.
- MS at the Paralympics
- Gene research for progressive MS questioned
- Natural history of people on disease modifying drugs
- MPs support call for medical cannabis
- Film about footballer with MS released on DVD
- Older people with MS
- Ageing with MS
- Progressive MS research funding
- Guidelines on more than one long-term condition
- ECTRIMS round up
Siponimod reduced the risk of progression in secondary progressive MS (SPMS) according to results presented at the ECTRIMS meeting in London on 17 September.
- How heat affects people with MS
- Paralympians with MS
- Negative attitudes to people with MS
- Tamoxifen may help myelin repair
- Genes don't suggest course of MS
A new report from the MS Trust shows that two in three people with MS in the UK live in areas where there aren’t enough MS nurses to provide vital care and support.
- The effect of childhood MS on parents
- Review of the medical understanding of childhood MS
- Explaining MS
- Please offer me a seat
- How lifestyle factors affect MS
- Photography project focuses on MS
- Low white blood cell count and MS
Initial research results suggest siponimod may slow progression in people with secondary progressive MS
- Genes and vitamin D
- Siponimod trial in secondary progressive MS
- Amiselimod trial results
The Patient Information Forum (PIF) are looking for people living with MS who may be interested in taking part in a focus group for its ‘perfect information journey’ project focused on improving access to information for patients with long-term conditions.
- Wales lagging behind in access to treatment
- High blood pressure may be associated with MS progression
- Neurological Alliance report on neurology and primary care
- Benefits changes and eligibility for Motability
- Camping with MS
People experiencing the first signs and symptoms of neurological conditions like MS are waiting too long to see an appropriate specialist, according to over 1,000 GPs surveyed across the UK.
Crystal tells us about her experience of living with MS and how it has led her to rekindle a love for jewellery making.
- Using mobility scooter for days out
- New technique for stem cell transplants
- Benefits of early treatment
Many MS symptoms seem invisible to other people. This blog explores some of the reasons for this and suggests what you could do to raise awareness.
As part of our MS Forward View project, we recently convened a meeting of MS specialists, carers and people with MS to look at different models of MS care and work out what are the most important factors to consider when designing services.